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Antineutrophil cytoplasm antibody-induced neutrophil nitric Nitric oxide (NO) plays a central role in the pathogen-
oxide production is nitric oxide synthase independent. esis of many inflammatory and infectious disorders [1].
Background. Antineutrophil cytoplasm antibodies (ANCAs) It can modulate inflammation through the inhibition ofare implicated in the pathogenesis of systemic vasculitis. We
platelet adherence and aggregation [2, 3], attenuation ofasked whether ANCA could induce nitric oxide (NO) release
neutrophil rolling [4, 5], and adherence to the endothe-from human neutrophils and, if so, whether this NO production
was dependent on NO synthase (NOS) activity. lium [4, 6, 7]. The cytotoxic effect of NO is contributed
Methods. Neutrophil NO production was measured using a to partly by the toxic oxidant peroxynitrite, formed by
chemiluminescence assay, and NOS activity was determined its reaction with superoxide, and by its ability to inhibitby the conversion of [14C] l-arginine to [14C] l-citrulline and NOS
the action of certain respiratory chain and iron sulfur-mRNA expression by reverse transcription-polymerase chain
bearing enzymes [8, 9]. These effects of NO may be rele-reaction (RT-PCR).
Results. Human neutrophils isolated from healthy donors vant to the neutrophil–endothelium interaction in the
were incubated at 378C with human ANCA, normal human antineutrophil cytoplasm antibody (ANCA)-associated
IgG, murine monoclonal myeloperoxidase ANCA, murine pro- vasculitis, which is characterized by a necrotizing vasculi-teinase-3 ANCA, or their respective isotypic controls for 6 to
tis with neutrophil infiltration and thrombosis.12 hours in RPMI. Both human and monoclonal ANCA led
Conventionally, NO is synthesized from l-arginine byto a dose-dependent increase of NO compared with control
IgG. Neutrophils, either freshly isolated or incubated for seven the enzyme NO synthase (NOS). At least three distinct
hours with murine monoclonal myeloperoxidase ANCA, pro- isoforms of NOS have been isolated and cloned [10–12].
teinase-3 ANCA, or a mixture of interleukin-1b, tumor necro- Two enzymes, the endothelial (eNOS) and the neuronealsis factor-a, interferon-g plus lipopolysaccharide showed no
(nNOS) isoforms, are constantly present and are termedNOS activity with low conversion rates of [14C] l-arginine to
constitutive NOS [10, 12]. The third isoform is inducible[14C] l-citrulline, which could not be inhibited by NG-mono-
methyl-l-arginine (NOS inhibitor). To detect NOS mRNA ex- (iNOS), and its expression can be induced by cytokines
pression, RT-PCR was performed using oligonucleotide prim- and/or endotoxin in a number of cells, including endothe-
ers derived from mRNA sequences of either human constitutive lium [10], hepatocytes [11], macrophages [13], smoothendothelial NOS (eNOS), constitutive neuroneal NOS (nNOS),
muscle cells [14], and chondrocytes [15]. The synthesisor human hepatocyte inducible NOS (iNOS). There was no ex-
of NO is largely due to an enzymatic reaction requiringpression of either eNOS, nNOS, or iNOS in untreated, human
and murine monoclonal ANCA-treated, or cytokine-treated the enzyme NOS in its production. However, a number
neutrophils. of observations have raised the possibility of a non-NOS
Conclusion. These data suggest that human neutrophils pro- pathway of NO synthesis. The urinary excretion of theduce NO in response to ANCA but in a NOS-independent way.
oxidation products of NO actually increased during ad-NO can be generated from a nonenzymatic interaction between
ministration of the NOS inhibitor NG-nitro-l-argininehydrogen peroxide and arginine. We postulate that this is the
predominant pathway of NO synthesis in neutrophils, since methyl ester in the anesthetized rat [16] and in the long-
ANCAs are capable of inducing reactive oxygen species pro- term incubation of isolated glomeruli [17]. Moreover, it
duction from neutrophils. was shown that the increase in urinary excretion of NO
oxidation products in conscious rats was the same whe-
ther the substrate was d- or l-arginine [18], despite theKey words: ANCA, systemic vasculitis, reactive oxygen species, in-
flammation, infection, thrombosis, oxydative stress. fact that NOS can only utilize l-arginine and not d-argi-
nine as its substrate to synthesize NO.Received for publication November 11, 1999
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or myeloperoxidase (MPO) with Fcg receptors on neu- exclusion and were 98 to 99% pure when stained with
hematoxylin.trophils, leading to degranulation and a respiratory burst
production [21, 22]. NO can attenuate the release of su-
IgG isolationperoxide by activated neutrophils by inhibiting the cyto-
Antineutrophil cytoplasm antibody-rich IgG was iso-assembly of nicotinamide adenine dinucleotide phosphate
lated from sera or plasma exchange samples from ANCA-(NADPH) oxidase, and in addition, scavenges superox-
positive vasculitis patients with active disease and com-ide [23, 24]. Activated human neutrophils use an MPO-
parable ANCA titers on indirect immunofluorescence.dependent pathway to convert nitrite, a stable metabolite
Control IgG was isolated from sera of normal subjects.of NO into the toxic nitryl chloride [25]. Colocalization
IgG isolation was performed using affinity chromatogra-of iNOS with MPO in neutrophil primary granules [26]
phy on a HiTrap protein G affinity column (Pharmacia,raises the possibility that reactive oxygen species and
Uppsala, Sweden) as previously described [39]. The pro-NO could have regulatory roles in the inflammation seen
tein content of the IgG sample was determined by spec-in the ANCA-associated vasculitides.
trometry at 280 nm using a Pharmacia LKB UltraspecDespite increasing evidence that NO has a role in
III (Pharmacia, Uppsala, Sweden). ANCA antigen speci-regulating the activities of neutrophils in inflammation,
ficity was determined by antigen-specific enzyme-linkedthe production of NO in human neutrophils is controver-
immunosorbent assay (ELISA) as previously describedsial. Rat neutrophils express an inducible isoform of NOS
[40]. Endotoxin contamination of IgG samples was mini-that is calcium and calmodulin independent [27, 28]. A
mal (,0.48 ng/mL), as determined by a Limulus amoebo-number of studies have shown low, but detectable, out-
cyte assay (Sigma, Poole, Dorset, UK).put of NO [29–31] or the presence of NOS in human
neutrophils [26, 32–34]. In contrast, other studies have Nitric oxide chemiluminescence
failed to show either the production of the NO metabo-
Nitric oxide was measured in the gas phase using alites, nitrite, and nitrate or the presence of NOS activity
Sievers NOA 270B NO chemiluminescent analyzer [41].in human neutrophils, even after activation with pro-
In solution, NO exists as dissolved gas and nitrite, whichinflammatory cytokines [35, 36]. The present study was
is in equilibrium with nitrous acid. As a product of theundertaken to examine the ability of human neutrophils
reaction of NO with oxygen in neutral aqueous solution,to release NO in response to ANCA and, if indicated, to
nitrite anion provides an indirect evidence of NO pro-determine whether this was NOS dependent. Neutrophil
duction [42]. One hundred microliter samples of cultureNO release was measured by the highly sensitive chemi-
medium were introduced into a nitrogen purge vesselluminescence detection method, and the specificity, sen-
containing a 1% solution of sodium iodide in glacial acetic
sitivity, and reproducibility of this assay has been ad-
acid to convert all dissolved NO and nitrite to gaseous
dressed previously [37]. NOS activity was measured by NO. NO then reacted with the ozone in the reaction
the [14C] l-arginine to [14C] l-citrulline conversion assay vessel to form activated nitrogen dioxide, which lumi-
and NOS mRNA expression by reverse transcription- nesced in the red and far red spectrum. Output from the
polymerase chain reaction (RT-PCR). To induce NOS analyzer was recorded on an integrating pen recorder
activity, both ANCA and a combination of cytokines and the area under the curve for each peak calculated
plus lipopolysaccharide were used. iNOS expression in and equated to moles of NO produced by each sample.
neutrophils obtained from infected peritoneal fluid was All samples were analyzed in triplicate. Calibration was
also examined, as it had been reported that bacterial achieved with a standard curve of sodium nitrite (10212
infection could induce iNOS in human neutrophils [34]. to 1024 mol/L). Intra-assay variability was 3.4 6 0.5%
(N 5 1000), and interassay variability was 4.5 6 1.1%
(N 5 30).METHODS
One 3 106 neutrophils were plated onto 96-well tissue
Neutrophil isolation
culture plates, stimulated with either murine monoclonal
Neutrophils were isolated using a method adapted from PR3-ANCA, 4A5 (gift from Dr. J. Weislander, Lund,
Toothill et al [38]. Peripheral blood was collected from Sweden), an isotype-matched control from the same lab-
healthy donors into tubes containing acid citrate dex- oratory, murine monoclonal MPO-ANCA (Dako, Glos-
trose (9:1 dilution). The blood cells were first sedimented trup, Denmark), its murine IgG1 isotypic control MM001
across Hespan (2.5% hydroxyethyl starch), and then neu- (Binding Site, Birmingham, UK), six human ANCA (3
trophils were isolated by density gradient centrifugation PR3-ANCA and 3 MPO-ANCA), or two normal IgG
at 500 3 g using isotonic percoll. Neutrophils were resus- for 0 to 12 hours at 378C. In some experiments, neutro-
pended in RPMI (GIBCO BRL, Paisley, UK), supple- phils were preincubated with the NOS inhibitor NG-
mented with 10% fetal calf serum (FCS) and 2.2 mmol/L monomethyl-l-arginine (1024, 1025, and 1026 mol/L), or
superoxide dismutase (250 and 500 U/mL). At the endglutamine. Neutrophils were 99% viable by trypan blue
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of the incubation period, the supernatant was removed quences of either human constitutive eNOS, nNOS, or
and stored at 2208C until analysis. Each experiment was human hepatocyte iNOS [10–12]. PCR amplification us-
performed at least three times. ing these oligonucleotide primers yielded PCR products
with a length of 422 bp (eNOS), 629 bp (nNOS), and
[14C] L-arginine to [14C] L-citrulline conversion assay 462 bp (iNOS). At the indicated times, cells were washed
Nitric oxide synthase activity was assayed by the con- in PBS and snap frozen in liquid nitrogen. RNA was
version of [14C] l-arginine to [14C] l-citrulline as described extracted using RNAzol (Biogenesis Ltd., Poole, UK),
previously [43] and was defined as citrulline formation and reverse transcription was performed as described
inhibitable by NG-monomethyl-l-arginine; 107 neutro- [47]. The PCR was carried out in an automatic DNA
phils were stimulated for seven hours at 378C with murine thermal cycler. For amplification of NOS cDNA, gene-
monoclonal MPO-ANCA (10 mg/mL), murine mono- specific primers recognizing motifs in the sequences of
clonal PR3-ANCA (20 mg/mL), or cytokines [100 U/mL constitutive eNOS, constitutive nNOS, and iNOS were
interleukin-1b (IL-1b), 10 ng/mL tumor necrosis factor-a used: eNOS sense (59-GTGATGGCGAAGCGAGTG
(TNF-a), 100 U/mL interferon-g (IFN-g), and 25 mg/mL AAG-39), eNOS antisense (59-CCGAGCCCGAACAC
lipopolysaccharide (LPS)]. The monoclonal ANCA con- ACAGAAC-39), nNOS sense (59-GTCGAATTCCG
centrations selected were those known to induce neutro- AATACCAGCCTGATCCATGGAA39), nNOS anti-
phil NO release (Figs. 2B and 3B). The cytokine concen- sense (59-CGCGGATCCCATGCGGTGGACTCCCT
trations selected were those previously reported to CCTGGA-39), iNOS sense (59-TCCGAGGCAAACA
induce iNOS in neutrophils [26] and other cell types [11, GCACATTCA-39), and iNOS antisense (59-GGGTTG
13, 14, 44, 45]. Control neutrophils were incubated in GGGGTGTGGTGATGT-39). The reaction mixture for
media only and remained for the same time period at the eNOS, nNOS, and iNOS PCR contained 5 mg cDNA,
378C. At the end of incubation, cells were washed twice 1 mmol/L sense and antisense primer, 200 mmol/L deoxy-
in phosphate-buffered saline (PBS) and resuspended in nucleotide triphosphates, and 1 U Tag polymerase (Pro-
homogenization buffer (pH 7.4) containing 10 mmol/L mega, Madison, WI, USA) in a final volume of 50 mL.
HEPES buffer, 0.32 mmol/L sucrose, 0.09 mmol/L ethyl- The cycle program for the eNOS and iNOS was set to
enediaminetetraacetic acid (EDTA), 1 mmol/L dithio- denature at 948C for 1 minute, to anneal at 608C for 1
threitol (DTT), 10 mg/mL leupeptin, 10 mg/mL soybean minute, and to extend at 728C for 1.5 minutes for a total
trypsin inhibitor, and 10 mg/mL aprotinin. Enzyme activ- of 35 cycles. For the nNOS PCR, the program was set
ity was released by rapid freezing in liquid nitrogen, to denature at 958C for 1 minute, to anneal at 608C for
followed by thawing at 378C three times. Homogenates 2 minutes, and to extend at 728C for 1 minute for a total
were subjected to centrifugation at 12,000 3 g for 20
of 35 cycles. As a control for cDNA synthesis, b-actin
minutes at 48C, and the supernatant was tested for NOS
specific primers were used: b-actin sense (59-CTGactivity. Briefly, 20 mL of the cell supernatant were added
GCATCCATGAAACCACC-39) and b-actin antisenseat 10-second intervals to 50 mL of assay buffer (pH 7.2)
(59-TGTTTTAGAAGCATTTGCGG-39). For the actinprewarmed to 378C. The final mixture contained 35
PCR, the cycle program was set to denature at 948C formmol/L dipotassium hydrogen phosphate, 0.7 mmol/L
30 seconds, to anneal at 508C for 40 seconds, and tomagnesium chloride, 143 mmol/L calcium chloride, 680
extend at 728C for 1 minute for a total of 35 cycles.mmol/L NADPH, 6.8 mmol/L l-valine, and 15 mmol/L
Negative controls for the RT step (no added RNA) and[14C] l-arginine. In some experiments, 70 mmol/L NG-
the PCR (no added cDNA) were performed to detectmonomethyl-l-arginine were present. After 10 minutes
contamination of the RT and PCR components. Theof incubation at 378C, 500 mL of a 1:1 suspension of
PCR products were visualized by ethidium bromideDowex were added, again at 10-second intervals. One
staining in a 1% agarose gel dissolved in TAE buffer.milliliter of double-distilled water was then added at
room temperature to each tube, and the resin was al-
Cell culture
lowed to settle for 15 minutes. Finally, 975 mL of the
Neutrophils. Human neutrophils isolated from healthysupernatant were added to 5 mL of Optiphase Hisafe II
donors were resuspended in RPMI, supplemented withfor scintillation counting. Homogenate from rat brain
10% FCS and 2.2 mmol/L glutamine and stimulated withwas used as the positive control for this assay, which is
either murine monoclonal MPO-ANCA (10 mg/mL),known to contain a constitutive, calcium-dependent
murine monoclonal PR3-ANCA (20 mg/mL), the corre-NOS form [46]. Each experiment was repeated at least
sponding isotypic-matched control IgG, or the combina-three times.
tion of 100 U/mL IL-1b, 10 ng/mL TNF-a, 100 U/mL
RT-PCR IFN-g, and 25 mg/mL LPS for 0 to 12 hours at 378C.
Human neutrophils were also extracted from the perito-Polymerase chain reaction was carried out using spe-
cific oligonucleotide primers derived from the mRNA se- neal fluid of four patients on peritoneal dialysis with
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bacterial peritonitis. Total mRNA was extracted from
4 3 107 neutrophils.
Human umbilical vein endothelial cells (HUVECs).
HUVECs were included as a positive control for consti-
tutive eNOS [10]. They were isolated from umbilical
cord veins by collagenase (Sigma) digestion based on
Gimbrone’s method [48]. They were cultured in M199
medium with 20% FCS, 90 mg/mL heparin, 20 mg/mL
endothelial cell growth factor, 2.2 mmol/L glutamine,
100 U/mL penicillin, and 100 U/mL streptomicin. The
cells were grown to near confluence in 75 cm2 tissue
culture flasks that had been coated with 1% gelatin. All
cells were used at the second or third passage. Endothe-
lial cell phenotype was confirmed by typical cobblestone
morphology and the presence of von Willebrand’s factor
antigen using rabbit anti-human von Willebrand’s factor
(Dako, Glostrup, Denmark). HUVECs were treated
with and without 100 U/mL IL-1b, 10 ng/mL TNF-a,
100 U/mL IFN-g, and 25 mg/mL LPS for 0 to 24 hours
at 378C.
HepG2 cells. The cell line HepG2 can be induced to
expresses iNOS with cytokine stimulation [11], and was
included as a positive control for the iNOS assay. One 3
106 cells were cultured in Dulbecco’s modified eagle me-
Fig. 1. Time course and dose response of human antineutrophil cyto-dium (DMEM), with 2.2 mmol/L glutamine, 1% human
plasm antibodies (ANCA) IgG-induced neutrophil nitric oxide (NO)
essential amino acid and 10% FCS, and were treated production in three replicate experiments. One 3 106 neutrophils were
plated onto 96-well tissue stimulated with IgG, and NO was measuredwith and without 100 U/mL IL-1b, 10 ng/mL TNF-a,
by a chemiluminescence assay. Time course was obtained using 500100 U/mL IFN-g and 25 mg/mL LPS for 0 to 8 hours at
mg/mL of IgG, and the dose response was measured at seven hours.
378C. Each experiment was repeated at least three times. Symbols are: (j)
myeloperoxidase (MPO)-ANCA; ( ) proteinase 3 (PR3)-ANCA; (h)
normal IgG.Statistical analysis
For the chemiluminescence NO measurement, differ-
ences between multiple groups were found by one-way
analysis of variance. Student t test was used to determine Murine monoclonal MPO-ANCA led to a time-depen-
NOS activity, as well as differences in NO output with dent (Fig. 2A) and concentration-dependent (Fig. 2B)
and without inhibitors. P , 0.05 was considered statisti- NO production that was significantly more than its
cally significant. isotypic murine monoclonal IgG control (P , 0.01,
ANOVA). Murine monoclonal PR3-ANCA also led to a
time-dependent (Fig. 3A) and concentration-dependentRESULTS
(Fig. 3B) NO production that was significantly more than
NO chemiluminescence its isotypic murine monoclonal IgG control (P , 0.01,
Both human MPO- and PR3-ANCA induced NO re- ANOVA).
lease from neutrophils (Fig. 1). At all of the concentra- Nitric oxide production from untreated and cytokine-
tions used (32.25 to 500 mg/mL), human PR3-ANCA treated HepG2 cells was also measured using the chemi-
induced significantly more NO than normal IgG [P , luminescence analyzer. At eight hours, NO could not
0.01, analysis of variance (ANOVA)]. Although human be detected in the culture medium of untreated-HepG2
MPO-ANCA also resulted in greater NO production cells, but cytokine-treated cells led to NO production
from neutrophils than normal IgG, this failed to reach (6.5 6 2.4 mmol/L, P , 0.05). NO production from
statistical significance (P . 0.05, ANOVA). However, HepG2 cells was additionally measured by the Griess
when the individual concentrations were compared, hu- reaction using a commercially available ELISA (Cayman
man MPO-ANCA resulted in significantly more NO pro- Chemical, Ann Arbor, MI, USA). At eight hours, NO
duction than normal IgG at the higher concentrations production could not be detected from untreated cells,
of 250 and 500 mg/mL (P , 0.05, t-test). The time course whereas cytokine-treated HepG2 cells led to NO produc-
of NO release was similar for both human PR3-ANCA tion (4.8 6 2.9 mmol/L, P , 0.05).
The addition of superoxide dismutase at the concen-and MPO-ANCA (Fig. 1A).
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Fig. 2. Time course and dose response of murine MPO-ANCA (j)
IgG-induced neutrophil NO production are shown in comparison with Fig. 3. Time course and dose response of murine PR3-ANCA ( )
its isotypic control IgG (h) in four replicate experiments. One 3 106 IgG-induced neutrophil NO production are shown in comparison with
neutrophils were plated onto 96-well tissue stimulated with IgG, and its isotypic control IgG (h) in four replicate experiments. One 3 106
NO was measured by a chemiluminescence assay. Time course was neutrophils were plated onto 96-well tissue stimulated with IgG, and
obtained using 10 mg/mL of IgG, and the dose response was measured NO was measured by a chemiluminescence assay. Time course was
at seven hours. obtained using 20 mg/mL of IgG, and the dose response was measured
at seven hours.
trations used (250 and 500 U/mL) significantly enhanced
NO production from murine MPO-ANCA or PR3- shared 99% identity with the constitutive eNOS isoform
ANCA–treated neutrophils (P , 0.05). These results are [10]. PCR of cytokine plus LPS-treated HepG2 cells
shown in Table 1. and HUVECs yielded an iNOS-specific amplification
product of 462 bp. Sequence analysis of this fragment
[14C] L-arginine to [14C] L-citrulline conversion assay displayed a 99% identity to human hepatocyte iNOS
Untreated, ANCA treated, or cytokine treated neu- mRNA (Fig. 4) [11].
trophils had very low [14C] l-arginine to [14C] l-citrulline Amplification of RNA samples directly, without re-
conversion (Table 2). The addition of NG-monomethyl- verse transcriptase, yielded no product, indicating that
l-arginine did not decrease the [14C] l-arginine to [14C] there was no contamination of the samples with cDNA
l-citrulline conversion in the neutrophil preparation, in- or genomic DNA. Similarly, no product was apparent
dicating that there was no NOS activity. In contrast, rat when the cDNA was omitted from the PCR step.
brain, which contains constitutive NOS, had significant
NOS activity, which was inhibitable by NG-monomethyl-
DISCUSSIONl-arginine.
This is the first in vitro study, to our knowledge, to
PCR examine the ability of human neutrophils to release NO in
response to ANCA. Using the chemiluminescence assay,Untreated human neutrophils from normal donors did
ANCAs clearly induce NO release from human neutro-not express the constitutive eNOS or nNOS. Neutrophils
phils. However, using the [14C] l-arginine to [14C] l-citrul-treated with cytokines plus LPS or murine monoclonal
line conversion assay, NOS activity was not detected.ANCA did not express iNOS mRNA. Likewise, neutro-
Further, untreated human neutrophils showed no evi-phils recovered from infected peritoneal fluid did not ex-
dence of constitutive NOS (eNOS and nNOS) activity bypress eNOS, nNOS, or iNOS. eNOS mRNA was found in
untreated HUVECs, and the sequence of this product PCR, whereas concurrent experiments using HUVECs
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Table 1. Effects of superoxide dismutase on the production of ANCA-induced nitric oxide from human neutrophils
Isotypic Isotypic
MPO-ANCA control IgG PR3-ANCA control IgG
Control 3.5610.5 3.664.8 9.964.7 2.361.9
SOD 250 U/mL 77.466.5a 1065.3a 41.063.5a 8.663.4a
SOD 500 U/mL 70.1610.3a 40.5610.3a 42.666.7a 10.165.4a
Nitric oxide (NO) in 10210 mol/L was measured by the chemiluminescence detection method. One 3 106 neutrophils were plated onto 96-well tissue stimulated
with either 10 mg/mL of murine monoclonal myeloperoxidase (MPO)-ANCA or 40 mg/mL of proteinase 3 (PR3)-ANCA, or their relevant isotypic control IgG for
7 hours. In some experiments, superoxide dismutase (SOD) was also added. Data are expressed as mean 6 SEM.
a P , 0.05 vs. control
Table 2. [14C] l-arginine to [14C] l-citrulline conversion assay showing nitric oxide synthase (NOS) activity in human neutrophils
Untreated Cytokine-treated
Rat brain neutrophils MPO-ANCA PR3-ANCA neutrophils
Without NG-monomethyl-l-arginine 4160650 1965 2564 1066 30 67
With NG-monomethyl-l-arginine 210665 1763 2166 2363 25 65
NOS is expressed as mean 6 SEM. Rat brain NOS is in pmol/min/g and neutrophil NOS is in pmol/min/107 neutrophils.
Fig. 4. Expression of constitutive endothelial
NOS (eNOS) and inducible NOS (iNOS)
mRNA in human cells. The mRNA of un-
treated and treated human umbilical endothe-
lial cells (HUVECs), HepG2, and neutrophils,
as well as neutrophils from infected peritoneal
fluid (PF) was isolated. Following reverse
transcription, PCR was carried out using spe-
cific primers for actin and NOS. Data show
one such representative experiment out of
three. Only the results for eNOS and iNOS
are shown. Neutrophils did not express the
constitutive forms of NOS (both eNOS and
iNOS) or the inducible form of NOS (iNOS).
unequivocally demonstrated the presence of constitutive RT-PCR. In contrast, cytokine- and LPS-treated HUVECs
and HepG2 cells clearly expressed iNOS mRNA. Neutro-eNOS using RT-PCR. Furthermore, the stimulation of hu-
man neutrophils with several inflammatory mediators phils recovered from infected peritoneal fluid also showed
no expression of either constitutive NOS or iNOS.known to induce iNOS in other cells [11, 13, 14, 44, 45]
did not result in conversion of [14C] l-arginine to [14C] The present data suggest that ANCA-induced NO pro-
duction from neutrophils is not through the classical NOSl-citrulline formation, nor was iNOS mRNA found on
Tse et al: ANCA-induced neutrophil NO production 599
system. This is supported by our findings that the NOS in- enge superoxide anions and further serve as a natural
protective mechanism against oxidative stress.hibitor NG-monomethyl-l-arginine did not inhibit ANCA-
In summary, ANCA can stimulate neutrophils to re-induced neutrophil NO production (data not shown).
lease NO, and this NO production appears to be NOSNagase et al have shown that NO can be synthesized
independent. However, the pathophysiological effects offrom d- or l-arginine and hydrogen peroxide without
this neutrophil-derived NO remain unknown, and the inrequiring NOS [49]. A number of observations also lend
vivo impact of neutrophil NO production in the ANCA-support to this route of NO synthesis. Rubanyi and Van-
associated vasculitis remains to be determined.houtte have shown that endothelium can release an en-
dothelium relaxing factor, presumed to be NO, in re-
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